Allena Pharmaceuticals, Inc. (ALNA) |
| 0.075 0.002 (3.16%) 09-07 16:00 |
| Open: | 0.0641 |
| High: | 0.1459 |
| Low: | 0.06 |
| Volume: | 252,311,606 |
| Market Cap: | 0(M) |
| PE Ratio: | -0.12 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.15 |
| Resistance 1: | 0.09 |
| Pivot price: | 0.07 |
| Support 1: | 0.01 |
| Support 2: | 0.01 |
| 52w High: | |
| 52w Low: |
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.
Financials
| EPS | -1.010 |
| Book Value | 0.440 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -96.0 |
| Return on Equity (ttm) | -278.1 |
Company news
Tue, 24 Feb 2026
ALNA Allena Pharmaceuticals NASDAQ Feb 2026 close $0.075, 252M vol: what’s next - Meyka
Fri, 20 Feb 2026
ALNA (Allena Pharmaceuticals) NASDAQ pre-market $0.08 Feb 20, 2026: heavy volume - Meyka
Thu, 12 Feb 2026
ALNA Allena Pharmaceuticals NASDAQ Intraday 12 Feb 2026: Volume up at $0.075 - Meyka
Mon, 09 Feb 2026
ALNA after hours: Allena Pharmaceuticals NASDAQ $0.075, watch catalysts - Meyka
Fri, 06 Feb 2026
ALNA Allena Pharma NASDAQ Pre-Mkt 06 Feb 2026: Vol 252.31M watch catalyst - Meyka
Tue, 06 Sep 2022
Allena Pharmaceuticals Shares Fall After Filing For Bankruptcy - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
